Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs
Acquisition expected to be neutral to adjusted earnings...
Ah, the eternal dance of geopolitical chess, where tariffs become the favorite weapon of choice for those claiming to defend the sanctity of national...
The VF 9 offers authentic comfort across its three rows of seating, perfectly suiting families with more than four members or those frequently traveling...
FREMONT, Calif., July 10, 2025 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the successful first...
All-new CX-5 takes Mazda's best-selling crossover to the next level
Updated design offers a bolder look with tie-ins to CX-70 and CX-90Innovative technology including Mazda's...
The global robotic surgery market size is calculated at USD 13.79 billion in 2025 and is expected to reach around USD 54.66 billion by 2034, growing at a CAGR of 16.54% for the forecasted period.
The global robotic surgery market size is calculated at USD 13.79 billion in 2025 and is expected to reach around USD 54.66 billion by 2034, growing at a CAGR of 16.54% for the forecasted period.
DELRAY BEACH, Fla., July 3, 2025 /PRNewswire/ --
What's fueling the shift from sterilization to scalability?
The global single-use surgical instruments market, valued at US$5.60 billion...
Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25% or more – according to data presented at ADA
According to DelveInsight's analysis, the current developmental pipeline for osteoarthritis is robust, with several companies initiating clinical trials to investigate new treatment options or...
LOS ANGELES, June 17, 2025 /PRNewswire/ -- Scientology Network's MEET A SCIENTOLOGIST, the weekly series spotlighting the everyday lives of Scientologists from around the...
SANDWICH, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis, is to present new data from its large-scale Phase II trial of LEVI-04 at EULAR, the European Congress of Rheumatology in Barcelona, Spain.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1